NP emphasized that if we had money, we would enroll 1000 patients quickly, like Gilead. This would make statistical significance easier to achieve and quicker , of course, is better.

He went on for awhile with this thread. So no money, low and slow enrollment. But he is rejected big money offers and working with Fife who has already been found to be at the least unethical. Also seems that the vaunted $10/share we heard about from the last Fife financing is going to evaporate and default to much worse terms if we raise more money at less than $10/share.